➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Harvard Business School
Medtronic
McKinsey
Dow
Baxter
McKesson

Last Updated: August 4, 2020

DrugPatentWatch Database Preview

AMPICILLIN TRIHYDRATE Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Which patents cover Ampicillin Trihydrate, and when can generic versions of Ampicillin Trihydrate launch?

Ampicillin Trihydrate is a drug marketed by Belcher Pharms, Dava Pharms Inc, Heritage Pharma, Ivax Sub Teva Pharms, Lederle, Mylan, Purepac Pharm, Sandoz, Vitarine, and Teva. and is included in fifteen NDAs.

The generic ingredient in AMPICILLIN TRIHYDRATE is ampicillin/ampicillin trihydrate. Six suppliers are listed for this compound. Additional details are available on the ampicillin/ampicillin trihydrate profile page.

Drug patent expirations by year for AMPICILLIN TRIHYDRATE
Recent Clinical Trials for AMPICILLIN TRIHYDRATE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Fundação de Amparo à Pesquisa do Estado de São PauloPhase 4
Federal University of São PauloPhase 4

See all AMPICILLIN TRIHYDRATE clinical trials

Pharmacology for AMPICILLIN TRIHYDRATE

US Patents and Regulatory Information for AMPICILLIN TRIHYDRATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Teva AMPICILLIN TRIHYDRATE ampicillin/ampicillin trihydrate FOR SUSPENSION;ORAL 061370-002 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Belcher Pharms AMPICILLIN TRIHYDRATE ampicillin/ampicillin trihydrate CAPSULE;ORAL 061602-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Vitarine AMPICILLIN TRIHYDRATE ampicillin/ampicillin trihydrate CAPSULE;ORAL 061387-003 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Mylan AMPICILLIN TRIHYDRATE ampicillin/ampicillin trihydrate FOR SUSPENSION;ORAL 061829-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Ivax Sub Teva Pharms AMPICILLIN TRIHYDRATE ampicillin/ampicillin trihydrate CAPSULE;ORAL 060765-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Dava Pharms Inc AMPICILLIN TRIHYDRATE ampicillin/ampicillin trihydrate CAPSULE;ORAL 062882-001 Feb 25, 1988 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Harvard Business School
Dow
Johnson and Johnson
Express Scripts
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.